** Shares of medical device maker Insulet PODD.O fall 3.1% to $149 premarket

** Co late on Tuesday said it is carrying out a voluntary correction of certain insulin pump pods after identifying a manufacturing issue

** Co said it does not expect supply disruptions and sees up to $50 million in related costs this year

** The action affects specific lots of its Omnipod product lines, representing about 8.5% of global pod production in 2025

** Brokerage BTIG lowers PT to $235 from $260, says "this is another, separate voluntary MDC following the MDC announced back in March, which also related to cannula tears"

** Brokerage says "this reduced multiple reflects continued negative investor sentiment and what we perceive to be some risk of reputation damage or increased regulatory scrutiny from this second voluntary MDC"

** Up to last close, stock down 45.9% YTD